Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model.

Spadazzi C, Recine F, Mercatali L, Miserocchi G, Liverani C, De Vita A, Bongiovanni A, Fausti V, Ibrahim T.

J Bone Oncol. 2019 Feb 27;16:100227. doi: 10.1016/j.jbo.2019.100227. eCollection 2019 Jun.

2.

Grading of Neuroendocrine Carcinomas: Correlation of 68Ga-PET/CT Scan with Tissue Biomarkers.

Liverani C, Bongiovanni A, Mercatali L, Foca F, Pieri F, De Vita A, Spadazzi C, Miserocchi G, Recine F, Riva N, Nicolini S, Severi S, Martinelli G, Ibrahim T.

Dis Markers. 2018 Dec 2;2018:6878409. doi: 10.1155/2018/6878409. eCollection 2018.

3.

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age.

Bongiovanni A, Recine F, Foca F, Fausti V, Riva N, Fabbri G, Severi S, Liverani C, De Vita A, Spadazzi C, Miserocchi G, Mercatali L, Amadori D, Ibrahim T.

Endocr Connect. 2018 Dec 1. pii: EC-18-0478.R1. doi: 10.1530/EC-18-0478. [Epub ahead of print]

4.

Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line.

Miserocchi G, De Vita A, Mercatali L, Recine F, Liverani C, Spadazzi C, Pieri F, Riva N, Bongiovanni A, Casadei R, Fausti V, Ibrahim T.

Cells. 2018 Oct 25;7(11). pii: E186. doi: 10.3390/cells7110186.

5.

Building machine learning force fields for nanoclusters.

Zeni C, Rossi K, Glielmo A, Fekete Á, Gaston N, Baletto F, De Vita A.

J Chem Phys. 2018 Jun 28;148(24):241739. doi: 10.1063/1.5024558.

PMID:
29960375
6.

Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers.

Mercatali L, Serra P, Miserocchi G, Spadazzi C, Liverani C, De Vita A, Marisi G, Bongiovanni A, Recine F, Pangan A, Masalu N, Ibrahim T, Amadori D.

J Vis Exp. 2018 Jun 11;(136). doi: 10.3791/57113.

PMID:
29939179
7.

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma.

De Vita A, Mercatali L, Miserocchi G, Liverani C, Spadazzi C, Recine F, Bongiovanni A, Pieri F, Cavaliere D, Fausti V, Amadori D, Ibrahim T.

J Vis Exp. 2018 Apr 11;(134). doi: 10.3791/56767.

PMID:
29708525
8.

Myxofibrosarcoma primary cultures: molecular and pharmacological profile.

De Vita A, Recine F, Mercatali L, Miserocchi G, Liverani C, Spadazzi C, Casadei R, Bongiovanni A, Pieri F, Riva N, Amadori D, Ibrahim T.

Ther Adv Med Oncol. 2017 Dec;9(12):755-767. doi: 10.1177/1758834017737472. Epub 2017 Oct 28.

9.

Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.

De Vita A, Recine F, Mercatali L, Miserocchi G, Spadazzi C, Liverani C, Bongiovanni A, Pieri F, Casadei R, Riva N, Fausti V, Amadori D, Ibrahim T.

Int J Mol Sci. 2017 Dec 8;18(12). pii: E2662. doi: 10.3390/ijms18122662.

10.

A long-range ordered array of copper tetrameric units embedded in an on-surface metal organic framework.

Lo Cicero M, Della Pia A, Riello M, Colazzo L, Sedona F, Betti MG, Sambi M, De Vita A, Mariani C.

J Chem Phys. 2017 Dec 7;147(21):214706. doi: 10.1063/1.5004082.

PMID:
29221400
11.

Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.

Bongiovanni A, Recine F, Celli M, Marcantognini G, Foca F, Liverani C, Fausti V, De Vita A, Miserocchi G, Mercatali L, Amadori D, Ibrahim T.

Medicine (Baltimore). 2017 Nov;96(46):e8567. doi: 10.1097/MD.0000000000008567. Review.

12.

Primary leiomyosarcoma of the bone: a case report and a review of the literature.

Recine F, Bongiovanni A, Casadei R, Pieri F, Riva N, De Vita A, Mercatali L, Liverani C, Spadazzi C, Miserocchi G, Fausti V, Amadori D, Ibrahim T.

Medicine (Baltimore). 2017 Nov;96(45):e8545. doi: 10.1097/MD.0000000000008545. Review.

13.

Management and potentialities of primary cancer cultures in preclinical and translational studies.

Miserocchi G, Mercatali L, Liverani C, De Vita A, Spadazzi C, Pieri F, Bongiovanni A, Recine F, Amadori D, Ibrahim T.

J Transl Med. 2017 Nov 7;15(1):229. doi: 10.1186/s12967-017-1328-z. Review.

14.

Toward Fractioning of Isomers through Binding-Induced Acceleration of Azobenzene Switching.

Vulcano R, Pengo P, Velari S, Wouters J, De Vita A, Tecilla P, Bonifazi D.

J Am Chem Soc. 2017 Dec 20;139(50):18271-18280. doi: 10.1021/jacs.7b09568. Epub 2017 Dec 5.

PMID:
29064236
15.

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines.

Mercatali L, Spadazzi C, Miserocchi G, Liverani C, De Vita A, Bongiovanni A, Recine F, Amadori D, Ibrahim T.

J Vis Exp. 2017 Sep 13;(127). doi: 10.3791/56311.

PMID:
28930982
16.

Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition.

Mercatali L, La Manna F, Miserocchi G, Liverani C, De Vita A, Spadazzi C, Bongiovanni A, Recine F, Amadori D, Ghetti M, Ibrahim T.

Int J Mol Sci. 2017 Jul 29;18(8). pii: E1655. doi: 10.3390/ijms18081655.

17.

Site accessibility tailors DNA cleavage by restriction enzymes in DNA confined monolayers.

Rotella C, Doni G, Bosco A, Castronovo M, De Vita A, Casalis L, Pavan GM, Parisse P.

Nanoscale. 2017 May 18;9(19):6399-6405. doi: 10.1039/c7nr00966f.

18.

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas.

Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T.

Onco Targets Ther. 2017 Feb 23;10:1155-1164. doi: 10.2147/OTT.S127955. eCollection 2017. Review.

19.

CORRECTION: Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model.

Liverani C, La Manna F, Groenewoud A, Mercatali L, Van Der Pluijm G, Pieri F, Cavaliere D, De Vita A, Spadazzi C, Miserocchi G, Bongiovanni A, Recine F, Riva N, Amadori D, Tasciotti E, Snaar-Jagalska E, Ibrahim T.

Biol Open. 2017 Feb 15;6(2):309. doi: 10.1242/bio.023911. No abstract available.

20.

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma.

De Vita A, Miserocchi G, Recine F, Mercatali L, Pieri F, Medri L, Bongiovanni A, Cavaliere D, Liverani C, Spadazzi C, Amadori D, Ibrahim T.

Molecules. 2016 Dec 3;21(12). pii: E1662.

Supplemental Content

Loading ...
Support Center